Shoreline Biosciences IPO

Shoreline Biosciences is a biotechnology company focused on immunotherapies for patients who are ill. Their core focus is on induced Pluripotent Stem Cells (iPSCs) and Macrophages (iMACs) which aim to target tumor and cancer cells. Shoreline Biosciences was founded in 2020 by Dan Kaufman, Kleanthis Xanthopoulos Ph.D, and Steven Holtzman and is headquartered in San Diego, CA.

Register for Details

For more details on financing and valuation for Shoreline Biosciences, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

What is Shoreline Biosciences's ticker symbol?

Shoreline Biosciences does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.

What is Shoreline Biosciences's stock price?

The stock price for Shoreline Biosciences will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).

Who are Shoreline Biosciences's major investors?

Boxer Capital
Paratus Investment

Shoreline Biosciences Funding Rounds and IPO Valuation

Date Funding Round Funding Raised Price per Share IPO Valuation
11/2/2021 Series B $140MM raised $XXX.XX $XXX.XX
2/7/2021 Series A $43MM raised $XXX.XX $XXX.XX
7/17/2020 Series Seed $3MM raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data

Learn more about Shoreline Biosciences

Forge green plus iconForge green minus icon

What is Shoreline Biosciences funding to date?

Shoreline Biosciences has raised $186MM with the following series:
$3MM raised for Series Seed,$43MM raised for Series A,$140MM raised for Series B.
Forge green plus iconForge green minus icon

When was Shoreline Biosciences founded?

Shoreline Biosciences was founded in 2020.
Forge green plus iconForge green minus icon

Can you invest in Shoreline Biosciences?

Shoreline Biosciences is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Forge green plus iconForge green minus icon

Can you sell Shoreline Biosciences share pre-IPO?

If you own Shoreline Biosciences pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.

Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.

Forge green plus iconForge green minus icon

Is Shoreline Biosciences a publicly traded company?

Shoreline Biosciences is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Other companies like Shoreline Biosciences in the Healthcare sector

Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$809.52MM
Sector
Last Round Est. Valuation
$1.01B
Sector
Last Round Est. Valuation
$4.26B
Sector
 
 
Sector
Last Round Est. Valuation
$396.01MM
Sector
Last Round Est. Valuation
$400.53MM
Sector
Last Round Est. Valuation
$1.53B